cbdMD, Inc. announced on December 23, 2024, that T. Ronan Kennedy, the company's Chief Executive Officer and Chief Financial Officer, has been appointed to its Board of Directors. This appointment became effective on December 18, 2024, expanding the board to five members.
Scott Stephen, Chairman of cbdMD's Board of Directors, stated that Kennedy has demonstrated exceptional leadership over the past two years in stabilizing the business. His efforts include reshaping cbdMD into a leaner, more efficient organization, optimizing its cost structure, and improving operational fundamentals.
The board believes Kennedy's strategic insight and deep understanding of the business will further enhance the company's ability to deliver value to shareholders. This move aims to strengthen governance and align leadership as cbdMD heads into 2025 with a stronger cash position and growth opportunities.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.